You have activated the high contrast version of the site. For more info on this topic, please visit this page.
In July 2017, the radiation oncology service carried out its first pulmonary radiotherapy treatment using a GPS navigation device for the human body.
This technology, used until now for prostate cancer, makes it possible to:
Its use in the treatment of lung cancer was discussed by a multidisciplinary group of experts from HUG’s cancer centre. This advance is the fruit of close collaboration, particularly with the pneumology service.
To treat the first patient, HUG applied a protocol of eight stereotactic radiotherapy sessions. It plans to extend it to other patients with lung cancer.